chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient reported a large bruise nearby the site of injection, first noted on Sunday, 6/12/22. Pt was unsure weather it was a side effect 10 days after the shot or something else that was causing it. Pt also described a feeling of "a knot" underneath the bruise when examined it with her fingers. Pt was referred to contact and consult with her provider.
glands were swollen; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (glands were swollen) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Celiac disease, Allergy and Asthma.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced LYMPHADENOPATHY (glands were swollen). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, LYMPHADENOPATHY (glands were swollen) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication not reported.   Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: Additional information received on 13-MAY-2021 Contains no new information
Pt given FLUBLOK vaccine; pt was too young to receive the shot per ACIP and manufacturer's recommendations. Parents contacted and are aware to call if problems arise. (Parents called same day vaccine was given).
At 1430, she received the COVID-19 vaccine and started feeling flushed, right-sided neck tightness, and throat constriction shortly afterwards. At 1435, she was given a dose of epinephrine and brought to the Emergency Department for further evaluation. Upon arrival to the Emergency Department, the patient reports feeling better. Her last menstrual period was 2 weeks ago. No rash or itching. No history of anaphylaxis to vaccines. No history of COVID-19 diagnosis. Denies pregnancy.
Dose #1 recieved May 27th, 2021. Dose #2 recieved June 17th, 2021. 6/26/21 2:00pm Grand Mal seizure (Full body convulsions, foaming at the mouth, eyes twitching and rolled back/up. Postictal immediately following seizure activity for roughly 10-15 minutes)  on June 26th, 2021, with no history of seizures or any other comorbidities. Resulted in an ER visit on 6/26/21. MRI and EEG ordered for testing. Lab worked ordered on 7/8/21. Rescue medication ordered in the event that he has another seizure. Outcomes: EEG showing absence seizure activity however that remains undetermined at this time due to the fact that the patient never displayed any physical evidence of an absence seizure during the test as he remained alert, responsive followed directions and was able to recall information, during the part of the test that displayed absence seizure activity. MRI: No acute infarct, intracranial hemorrhage or mass effect. Referral to pediatric neurologist.
12 hours after injection had tremors in extremities, especially arms and hands, lasted 45 minutes then went away.  1/2 hour later tremors got worse but only in arms and hands - went to bed and woke up fine. Today, 3/5, very dizzy, went to bed that way and still can't walk without feeing I am going to fall down.
Patient received 2 AstraZeneca doses & was given a booster of Moderna. After administration I discovered that patient should have received a Pfizer. I will inform patient of error.
Fever of 101, extreme chills, sweating, sore throat, sore ears, headache, body aches, minor stomach upset.   Symptoms started approx. 28 hours after injection and lasted about 15 hours.  Rapid onset and stopped all at once.
When I checked into Walgreens I was asked if I had had any reaction to any vaccines.  I said no.  This was my first shot.  I am scheduled for the 2nd shot on the 27th of April. I was not asked if I had had a severe allergic reaction to anything else.  I had my shot, not monitored.  Just called the next patient in, and I walked out the door to drive home.  Within ten minutes, I started having tingling on the top of my ears, cheeks, inside my mouth, top of my head and down the back of my neck.  I was itchy all over.  My head, back of my neck, arms, all over.   I have had an anaphylaxis reaction to bee stings and fire ants many years ago, so I recognized the feeling.  I drove home and took some over the counter allergy medicine and laid down.  I did not have trouble breathing, but the tingling lasted for a few hours.
Scratchy throat, Lump in lip. Throat was swollen and could not swallow. Benadryl
Patient developed diffuse urticaria and facial swelling after receiving Menactra.  Patient presented to the Emergengy Department and required sq epinephrine, IV diphenhydramine and IV dexamethasone.
pt fainted after being administering janssen covid vaccine. regained conscous within a few seconds and laid on the floor for about 30 minutes until he felt better.
Pt developed a papular eruption within 24 hours, post vax, progressive and required systemic prednisone therapy.
This spontaneous report was received from a medical assistant referring to a 21 year old patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 23-JUN-2017, the patient was vaccinated with an improperly stored dose of GARDASIL 9 with lot # M036059 and expiration date 03-JUN-2019 (dose and route of administration were not reported) for prophylaxis. There was no adverse effect or product quality complaint reported. No excursion details had been determined at the time of the report. There was a data logger involved. This is one of several reports received from the same reporter. Follow up information was received on 18-SEP-2017 from the medical assistant, concerning GARDASIL 9 with lot # M036059. On 11-MAY-2017 at 12:24, the time in the range 32°Fahrenheit (°F) to 35°F (0°C to 1°C) was 1 hour at 34.9°F, number of cycles 1. On the same day at 21:24, the time in the range 32°F to 35°F (0°C to 1°C) was 1 hour at 34.9°F, number of cycles 8. On 12-MAY-2017 at 03:24, the time in the range 32°F to 35°F (0°C to 1°C) was 1 hour at 34.9°F, number of cycles 5. On 13-MAY-2017 at 05:24, the time in the range 32°F to 35°F (0°C to 1°C) was 1 hour at 34.9°F, number of cycles 26. On 14-MAY-2017, the time in the range 32°F to 35°F (0°C to 1°C) was 2 hours from 16:24 to 18:24, number of cycles 21. On the same day at 20:24, the time in the range 32°F to 35°F (0°C to 1°C) was 1 hour at 34.9°F, number of cycles 1. On 15-MAY-2017, the time in the range 32°F to 35°F (0°C to 1°C) was 3 hours from 01:24 to 04:24, number of cycles 4. On the same day at 12:24, the time in the range 32°F to 35°F (0°C to 1°C) was 1 hour at 34.9°F, number of cycles 7. It has been determined that case # 1710USA009230 was created with the wrong Aware date as 02-OCT-2017 which is previous of the correct Aware date 18-SEP-2017. Therefore, case # 1710USA009230 is being deleted from our files and the case is consolidated into case # 1711USA004084 with the correct Aware Date 18-SEP-2017. Sender's Comments: US-009507513-1708USA011654.
Developed trigger finger in my little finger and ring finger on right hand about two days after the first dose of Pfizer Covid vaccine. Never had trigger finger before or any joint problems. I am a musician and this has limited my ability to play and make a living. I have no treatment since I have no insurance and no regular doctor. Symptoms are worst in the morning when I wake up.
Started with some dizziness and lethargy, shortness of breath, then a  slight fever that slowly increased to 99.8 at high point over the next 24 hours, some nausea and diarrhea, increase in headache and swollen/dry eyes.  Temperature gradually reduce over the next 12 hours and other symptoms faded as well.  Used Acetaminophen and Ventolin to treat symptoms. isolated during course of fever.
Localized swelling, induration of entire shoulder. Treated w/BENADRYL.
This case was reported by a nurse via call center representative and described the occurrence of swollen tongue in a 63-year-old female patient who received BOOSTRIX (batch number TX34X, expiry date 14th May 2017). Concurrent medical conditions included food allergy (Corn allergy). On an unknown date, the patient received BOOSTRIX .5 ml. On an unknown date, less than a day after receiving BOOSTRIX, the patient experienced swollen tongue and pharyngeal paresthesia. On an unknown date, the outcome of the swollen tongue and pharyngeal paresthesia were recovered/resolved. It was unknown if the reporter considered the swollen tongue and pharyngeal paresthesia to be related to BOOSTRIX. Additional details were provided as follows: The reporter stated that, the patient experienced tongue swelling and throat tingling shortly after receiving the BOOSTRIX. The events subsided shortly after.
Patient received her 2nd dose of the Pfizer Covid 19 vaccine at 8:30 am. At approximately 9:48 am she returned appearing flushed and reporting that she felt very warm and was having trouble cooling down. She appeared 'blotchy' on her upper chest region, but no rash or hives anywhere else on her body. We had her lay down and checked a blood pressure, with a result of 132/70. Cold compresses were applied to the back of the neck and the forehead to help cool her down. Later rotated from the back of the neck to the upper chest/neck region. Patient was observed for 15-20 minutes by the administering pharmacist and nursing staff. During that time she appeared less flushed and redness on the chest region improved. She reported feeling improved and returned to work, with regular checks made by nursing staff to ensure symptoms did not return.
after 1st Moderna dose he felt uncomfortable but that was bearable; Soreness and Pain all over; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (after 1st Moderna dose he felt uncomfortable but that was bearable) and MYALGIA (Soreness and Pain all over) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     Concurrent medical conditions included Polymyalgia since 2012 and Blood pressure (Patient is taking blood pressure medication). Concomitant products included PREDNISONE for Polymyalgia.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced DISCOMFORT (after 1st Moderna dose he felt uncomfortable but that was bearable) and MYALGIA (Soreness and Pain all over). At the time of the report, DISCOMFORT (after 1st Moderna dose he felt uncomfortable but that was bearable) and MYALGIA (Soreness and Pain all over) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Treatment information was reported.   This case was linked to MOD-2021-114818 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2021: Event term was added. Event outcome was updated. On 22-Jul-2021: Medical history start date, Concomitant medication dosage details and dose 2 information updated
A non-serious spontaneous report of chills has been received from a consumer concerning a 14-year-old male, subsequent to H1N1, Intranasal. Neither relevant medical history nor concomitant medications have been reported for this patient. The patient received a single dose of H1N1, Intranasal on 16-Oct-2009. On 20-Oct-2009, the patient developed chills and was sent home from school. The outcome for the reported event was not provided.
It has been almost 6 weeks and my arm is STILL very stiff and sore where the vaccine was injected. The pain becomes very bothersome and occasionally affects the usage of my left arm.
hives around the vaccination site about across two inches; itching at the injection site; nauseous; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE URTICARIA (hives around the vaccination site about across two inches), NAUSEA (nauseous), PAIN IN EXTREMITY (Sore arm) and VACCINATION SITE PRURITUS (itching at the injection site) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     The patient's past medical history included No adverse event.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced NAUSEA (nauseous) and PAIN IN EXTREMITY (Sore arm). On 11-Feb-2021, the patient experienced VACCINATION SITE URTICARIA (hives around the vaccination site about across two inches) and VACCINATION SITE PRURITUS (itching at the injection site). On 05-Feb-2021, NAUSEA (nauseous) and PAIN IN EXTREMITY (Sore arm) had resolved. On 12-Feb-2021, VACCINATION SITE URTICARIA (hives around the vaccination site about across two inches) and VACCINATION SITE PRURITUS (itching at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
This case was reported by a physician via a general injectables and vaccines wholesaler and described the occurrence of shoulder pain in a 59-year-old female subject who was vaccinated with (FLULAXAL, GlaxoSmithKline).  In 2008 the subject received unspecified dose of FLULAVAL (unknown).  In 2008, at an unspecified time after vaccination with FLULAVAL, the subject experienced left shoulder pain and was unable to lift the arm.  At the time of reporting the outcome of the events was unspecified.
facial pressure and pain, severe sinus inflammation, no phlegm, headache, body ache, stiff neck and pain, fever, chills. I had fever on the second day then chills in the night. Later, in the middle of the night, i started sweating a lot then in the morning, fever was gone but facial pressure remained.
4 y/o previously healthy boy with history of erythema multiforme reaction to penicillin (3/16/09) took H1N1 FLUMIST 10/15/09 and developed itchy hive like rash 10/18/09. Seen in clinic 10/19 for hives (some almost erythema multiforme appearing).
Information has been received from a licensed practical nurse concerning a 16 month old 27 lb. 31 in. female with no pertinent medical history and no drug reactions/allergies, who on 18-OCT-2007 at 11:00 hrs. was vaccinated intramuscularly in the right thigh with a first 0.5 mL dose of varicella virus live (Oka/Merck) (lot# 654523/1155F). There was no reported illness at the time of vaccination, and no adverse events following prior vaccination. There was no concomitant medication. On 30-OCT-2007, the patient developed a widespread vesicular rash described as a red colored raised skin lesions. On 31-OCT-2007, the patient was examined in the office and diagnosed with chickenpox. There were no lab diagnostic studies performed. Treatment included acyclovir, 150 mg orally, three times a day for 10 days. At the time of this report, on an unspecified date the patient had recovered. The reporter felt that the chicken pox was vaccine induced. There was no product quality complaint. Additional information is not expected.
her face swollen; Face and neck extremely hot; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (her face swollen) and FEELING HOT (Face and neck extremely hot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SWELLING FACE (her face swollen) and FEELING HOT (Face and neck extremely hot). At the time of the report, SWELLING FACE (her face swollen) and FEELING HOT (Face and neck extremely hot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Patient felt weak 30 minutes after vaccine given, vital signs stable no breathing problems, was able to walk but wanted to go to ED. He felt too weak to drive. ambulance was called and he walked to ambulance
fatigue; This spontaneous case was reported by a patient family member or friend (subsequently medically confirmed) and describes the occurrence of FATIGUE (fatigue) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     Concomitant products included lisinopril, LEVOTHYROXINE SODIUM (SYNTHROID) and ROSUVASTATIN CALCIUM (CRESTOR) for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced FATIGUE (fatigue). The patient was treated with AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) at an unspecified dose and frequency. On 14-Feb-2021, FATIGUE (fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication include Adderall.   This case was linked to US-MODERNATX, INC.-MOD-2021-070500 (E2B Linked Report). This case was linked to MOD-2021-070500 (Patient Link).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-070500:Dose 1
Pt very sleepy 3 d. after vaccine Hep A. Also was off balance at home.
Bottom lip tingly, puffy and numb.  Also, top of throat felt that it was swollen and dry.  Coughing as well. Chest area felt a burning sensation.  Took a dose of oral Benadryl and that helped and the symptoms are waning after 2 hours post vaccination, but still have some tingling to the lower lip.
very severe pain in her extremities; Pain in back; cramps; loos her breath; she was shivering; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (very severe pain in her extremities), BACK PAIN (Pain in back), MUSCLE SPASMS (cramps), DYSPNOEA (loos her breath) and CHILLS (she was shivering) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced PAIN IN EXTREMITY (very severe pain in her extremities), BACK PAIN (Pain in back), MUSCLE SPASMS (cramps), DYSPNOEA (loos her breath) and CHILLS (she was shivering). At the time of the report, PAIN IN EXTREMITY (very severe pain in her extremities), BACK PAIN (Pain in back), MUSCLE SPASMS (cramps), DYSPNOEA (loos her breath) and CHILLS (she was shivering) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
On day 5 following vaccination (8/15/21), patient began to develop an itchy rash on multiple areas of the body.  On day 6 (8/16/21) rash was covering entire body from head to toes and patient was experiencing intense itching everywhere.  He called the pharmacy for advice and to report this rash on 8/16/21 at 12:20pm and had already taken diphenhydramine.  I recommended he try to get in to see his primary care, have a teledoc visit or go to urgent care.  He was not having any swelling of the face, tongue, lips or throat and was not having difficulty breathing.
pt recvd vax SEP93 & devel nausea & vomiting; the next day devel severe pain in both shoulder & throughout body; subsequently lost the use of arms; adm to hosp where was given a dx of GBS;
Client stated, within 4 hours after receiving Hep-B injection, she began to break out with rash in pelvic area and large bumps on arms and lower legs which became hot, flushed with periods of coolness to body.
I just have a little bit of itching at the injection site/lip started to feel itchy; I just have a little bit of itching at the injection site/lip started to feel itchy; Numbness of tongue; This is a spontaneous report from a contactable consumer, the patient. A 45-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EP7534), intramuscularly, administered in arm left on 18Mar2021 (45-years-old at the time of vaccination) as single dose for covid-19 immunization. The patient's medical history was not reported. Concomitant medication included fexofenadine hydrochloride (ALLEGRA). On 18Mar2021, right away after the shot may be two minutes, patient started feeling and said to the nurse that her tongue has got numb and she told her it's her nerve, until she sat in the chair and waited for 20 minutes and then she told that her tongue was still numb but they told her that it's nerves again, she was free to go and now they were here after 90 minutes after her shot and still her tongue was numb so she didn't feel like that normal. She also stated her top lip started to feel itchy. Her breathing was fine, she never had a problem with the breathing it's just the tongue thing that won't go away, she just had a little bit of itching at the injection site and still have a little bit of itching it's not anything crazy, it's not a big deal. She stated that she really have a weak immune system, Like she was allergic to everything and went to anaphylactic reactions twice. She was now getting some allergy shot once a week. She was not even sure what allergy shots was being honest, she just knows that when they did the 144 shots whatever in back, she was having all 144 things. Last week was her first time after the rush therapy and she is suppose to go tomorrow to get my injection, Tomorrow will be 19Mar, She just want to know if her tongue is going to stop being numb. Consumer stated, Its 08Apr2021 for Second date of vaccine. When probed for the route of administration of the vaccine, the consumer stated, It was an IM. When probed for the anatomical site of administration of the vaccine the consumer stated, It was my left arm. Event outcome was not resolved for all.  Follow-up attempts completed. No further information expected.
Information has been received from a registered nurse concerning a 68 year old female who on 01-APR-2008 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (Lot# 659149/1383U). On approximately 03-APR-2008 the patient had a reaction from pneumococcal 23v polysaccharide vaccine. It was reported that the patient developed a "swollen arm from her shoulder elbow" and "it is very tight". The patient went to the emergency room on 03-APR-2008 and it was reported that she was "going to be admitted". At the time of the report, the patient had not recovered. The nurse requested a lot check for Lot#659149/1383U. A standard lot check investigation was performed. All in-process quality checks for the lot number in question were satisfactory. The lot met the requirements of the Center for Drug Evaluation and Research and was released. Additional information has been requested.
Case number PHEH2014US022726, is an initial spontaneous report from a pharmacist received on 10 Nov 2014. This report refers to a 28-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. She was vaccinated with FLUVIRIN (batch number: 145304) intramuscularly on 08 Oct 2014. On an unknown date after vaccination, the patient arm was hurting and it was hard for her to put her shirt on. She also reported pain at the injection site and it was over a month now she received the vaccine. The pharmacist reported that the patient stated that vaccine was given high up (no further details provided). The outcome of the events was unknown. Seriousness and causality was not reported. The patient does not have a treating physician.